These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31048443)
1. Protocol for a controlled human infection with genetically modified Gbesemete D; Laver JR; de Graaf H; Ibrahim M; Vaughan A; Faust S; Gorringe A; Read RC BMJ Open; 2019 May; 9(4):e026544. PubMed ID: 31048443 [TBL] [Abstract][Full Text] [Related]
2. Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study. Deasy AM; Guccione E; Dale AP; Andrews N; Evans CM; Bennett JS; Bratcher HB; Maiden MC; Gorringe AR; Read RC Clin Infect Dis; 2015 May; 60(10):1512-20. PubMed ID: 25814628 [TBL] [Abstract][Full Text] [Related]
3. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555 [TBL] [Abstract][Full Text] [Related]
4. A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage. Laver JR; Gbesemete D; Dale AP; Pounce ZC; Webb CN; Roche EF; Guy JM; Berreen G; Belogiannis K; Hill AR; Ibrahim MM; Ahmed M; Cleary DW; Pandey AK; Humphries HE; Allen L; de Graaf H; Maiden MC; Faust SN; Gorringe AR; Read RC Sci Transl Med; 2021 Jul; 13(601):. PubMed ID: 34233953 [TBL] [Abstract][Full Text] [Related]
5. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease? Gorringe AR Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250 [TBL] [Abstract][Full Text] [Related]
6. Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial. Dale AP; Theodosiou AA; Gbesemete DF; Guy JM; Jones EF; Hill AR; Ibrahim MM; de Graaf H; Ahmed M; Faust SN; Gorringe AR; Polak ME; Laver JR; Read RC Lancet Microbe; 2022 Dec; 3(12):e931-e943. PubMed ID: 36462524 [TBL] [Abstract][Full Text] [Related]
8. Controlled human infection with Theodosiou AA; Laver JR; Dale AP; Cleary DW; Jones CE; Read RC BMJ Open; 2022 May; 12(5):e056081. PubMed ID: 35584870 [TBL] [Abstract][Full Text] [Related]
9. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies. Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703 [TBL] [Abstract][Full Text] [Related]
11. Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB. Bennett JS; Callaghan MJ; Derrick JP; Maiden MCJ Microbiology (Reading); 2008 May; 154(Pt 5):1525-1534. PubMed ID: 18451061 [TBL] [Abstract][Full Text] [Related]
12. The use of monoclonal antibodies to Neisseria lactamica in an antigen selection to Neisseria meningitides B vaccine. De Gaspari EN Hybridoma (Larchmt); 2008 Oct; 27(5):387-93. PubMed ID: 18803504 [TBL] [Abstract][Full Text] [Related]
13. Genetic diversity and carriage dynamics of Neisseria lactamica in infants. Bennett JS; Griffiths DT; McCarthy ND; Sleeman KL; Jolley KA; Crook DW; Maiden MC Infect Immun; 2005 Apr; 73(4):2424-32. PubMed ID: 15784588 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and molecular characterization of Neisseria lactamica carried in 11-19 years old students in Salvador, Brazil. Moura ARSS; Kretz CB; Ferreira ÍE; Nunes AMPB; de Filippis I; de Moraes JC; Reis MG; McBride AJA; Wang X; Campos LC Int J Med Microbiol; 2018 Jun; 308(4):454-458. PubMed ID: 29605532 [TBL] [Abstract][Full Text] [Related]
15. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. Vaughan AT; Gorringe A; Davenport V; Williams NA; Heyderman RS J Immunol; 2009 Feb; 182(4):2231-40. PubMed ID: 19201877 [TBL] [Abstract][Full Text] [Related]
16. Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece. Kremastinou J; Tzanakaki G; Levidiotou S; Markou F; Themeli E; Voyiatzi A; Psoma E; Theodoridou M; Blackwell CC FEMS Immunol Med Microbiol; 2003 Oct; 39(1):23-9. PubMed ID: 14556992 [TBL] [Abstract][Full Text] [Related]
17. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443 [TBL] [Abstract][Full Text] [Related]
19. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Gorringe A; Halliwell D; Matheson M; Reddin K; Finney M; Hudson M Vaccine; 2005 Mar; 23(17-18):2210-3. PubMed ID: 15755597 [TBL] [Abstract][Full Text] [Related]